Pino, A.; Vaccalluzzo, A.; Cianci, S.; Palumbo, M.; Caruso, G.; Caggia, C.; Randazzo, C.L.
Oral Administration of the Probiotic Lacticaseibacillus rhamnosus CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study. Microorganisms 2025, 13, 2651.
https://doi.org/10.3390/microorganisms13122651
AMA Style
Pino A, Vaccalluzzo A, Cianci S, Palumbo M, Caruso G, Caggia C, Randazzo CL.
Oral Administration of the Probiotic Lacticaseibacillus rhamnosus CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study. Microorganisms. 2025; 13(12):2651.
https://doi.org/10.3390/microorganisms13122651
Chicago/Turabian Style
Pino, Alessandra, Amanda Vaccalluzzo, Stefano Cianci, Marco Palumbo, Giuseppe Caruso, Cinzia Caggia, and Cinzia L. Randazzo.
2025. "Oral Administration of the Probiotic Lacticaseibacillus rhamnosus CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study" Microorganisms 13, no. 12: 2651.
https://doi.org/10.3390/microorganisms13122651
APA Style
Pino, A., Vaccalluzzo, A., Cianci, S., Palumbo, M., Caruso, G., Caggia, C., & Randazzo, C. L.
(2025). Oral Administration of the Probiotic Lacticaseibacillus rhamnosus CA15 in a Large Cohort of Women with Bacterial Vaginosis and Mixed Vaginitis: Clinical Evidence from a Randomized, Double-Blind, Placebo-Controlled Study. Microorganisms, 13(12), 2651.
https://doi.org/10.3390/microorganisms13122651
